Royal Dutch Shell and ExxonMobil have mandated Bank of America to evaluate a potential sale of their 50-50 specialty chemicals joint venture, Infineum, in a transaction that could value the British-based additive manufacturer at roughly $8 billion, according to reports by the Financial Times cited by Reuters.
Assessing the Infineum Portfolio Valuation and Corporate Divestment Strategy
- Asset Valuation: The proposed sale of the 50-50 joint venture between Shell and ExxonMobil is targeted at an estimated $8 billion valuation.
- Advisory Mandate: Bank of America has been retained to run the review and explore potential private equity or strategic suitors, though the companies emphasize the process remains exploratory.
- Corporate Refocusing: The discussions align with broader portfolio adjustments across the energy majors, running concurrently with Shell’s ongoing share buyback operations and recent upstream divestments.
Bank of America Mandated as Advisers for British Chemicals Venture
The joint venture, headquartered in the United Kingdom, produces petroleum additives and lubricant components used globally across automotive and industrial sectors. Market observers note that the exploration of an $8 billion exit reflects a broader strategic pivot by traditional energy majors away from non-core chemical assets to concentrate capital on upstream oil and gas operations. As reported by the BOE Report, the sales process remains in early stages, with no certainty that an agreed disposal will materialize.
Representatives for Shell declined to comment on the Financial Times report. Meanwhile, ExxonMobil, Infineum, and Bank of America did not immediately respond to requests for comment from reporters Yamini Kalia, Maju Samuel, and Devika Syamnath.
Concurrent Share Repurchases and Upstream Activity
While discussions regarding the specialty chemicals venture advance, Shell has maintained active capital allocation through its ongoing share repurchase program. As detailed by ad-hoc-news.de, the energy major kept its buyback desk running through the back half of October. On Friday, the company acquired 1,027,233 shares on the London Stock Exchange and 515,198 shares on Euronext Amsterdam, with all acquired equities earmarked for cancellation.

These transactions mirror purchase volumes executed earlier in the week. On Thursday, Shell bought 1,075,000 shares in London and 535,000 shares in Amsterdam. Going back to 21 October, the firm picked up 1,025,000 shares on the LSE and 525,000 on XAMS under the same cancellation mandate.
| Transaction Date | London Stock Exchange (LSE) Shares | Euronext Amsterdam (XAMS) Shares |
|---|---|---|
| 21 October 2026 | 1,025,000 | 525,000 |
| 22 October 2026 | 1,075,000 | 535,000 |
North Sea Jackdaw Approval and African Divestment Timeline
Beyond capital distribution and chemical portfolio reviews, operational milestones continue to shape the firm’s balance sheet. On 21 October, the UK government granted regulatory approval for gas production at the North Sea Jackdaw field. Operated by Adura—a joint venture between Shell and Equinor—the field holds the potential to commence gas supply before the end of October, a timeline highlighted by government officials as an incremental boost to British energy security.

In parallel, international asset footprints continue to contract. On 13 October, Shell reached an agreement to sell its entire interest in the Shell Nigeria Gas Group to Vaaris Energy. Completion of the Nigerian divestment is anticipated in the first half of 2027, pending customary regulatory approvals, with financial terms remaining undisclosed.
Upcoming Financial Disclosures and Market Reaction
Investors will receive further clarity on corporate performance and capital allocation strategies when Shell publishes its third-quarter financial results. In the preceding trading session prior to the quarterly update, Shell stock slipped 0.9% as broader equities weighed macroeconomic indicators and shifting commodity pricing.
Disclaimer: The information provided in this article is for educational and informational purposes only and does not constitute financial advice.